Nonclinical Efficacy Testing » Non-Clinical CROs and Agencies » Food and Drug Safety Center (FDSC)

Food and Drug Safety Center (FDSC)

Table of Contents
Table of Contents

The Food and Drug Safety Center (FDSC) provides safety testing of pharmaceuticals, medical devices, health foods, and other related products.

This page provides detailed information about FDSC’s non-clinical studies, examples of disease models, and case studies.

We hope it serve as a useful reference when selecting a contract organization for your needs.

Features of the FDSC’s Non-Clinical Testing Services

Providing Safety Testing Based on Multiple Guidelines

FDSC provides high-quality safety testing in compliance with various guidelines.

In addition to the Ministry of Health, Labour and Welfare (MHLW) guidelines, they perform evaluations according to the recommendations by international standards such as ISO 10993, FDA, ASTM, and OECD.

Since 1970, FDSC has been engaged in a wide range of safety evaluations related to food, pharmaceuticals, and medical devices.

As of October 2024, the Center had conducted over 70,000 tests in total.

They have worked with numerous manufacturers for their biological safety testing of medical devices.

Beyond providing test results, FDSC offers comprehensive follow-up services, including consultations regarding inquiries from regulatory authorities based on study outcomes.

Reference: Food and Drug Safety Center official website —https://www.fdsc.or.jp

Extensive Range of Safety Tests

FDSC supports a broad spectrum of safety tests, including cytotoxicity, skin sensitization, local irritation, systemic toxicity, genotoxicity, pathological examinations, implantation, blood compatibility, extraction efficiency, and quality control tests and more.

Since 1980, they have provided many GLP compliant studies and can also perform quality control testing in accordance with GMP standards.

Partnered Organizations

No information regarding partnered organizations was found on the official website.

Example of a Non-Clinical Study at the FDSC

Single-Dose Toxicity (Acute Toxicity) Study

Extracts of pharmaceuticals, chemicals, or medical materials are administered once to animals (e.g., mice or rats) orally, intravenously, or dermally, to observe potential toxic effect.

Evaluation items include general condition, body weight change, and pathological examination.

Reference: Food and Drug Safety Center official website —https://www.fdsc.or.jp/contract/contract_service/medicine.html

Repeated-Dose Toxicity Study

This study aims to evaluate toxicological changes in animals administered daily or implanted with medical devices over periods ranging from two weeks to one year.

Mice, rats, and rabbits are used as test species, with evaluations including general condition, body weight change, food and water intake, urinalysis, hematology, ophthalmology, and pathological examination.

Reference: Food and Drug Safety Center official website —https://www.fdsc.or.jp/contract/contract_service/medicine.html

Company Information

The Food and Drug Safety Center conducts tests in accordance with international standards such as ISO 10993, FDA, ASTM, and OECD, as well as the guidelines of Japan’s Ministry of Health, Labour and Welfare (MHLW).

Address 729-5 Ochiai, Hadano City, Kanagawa Prefecture, Japan
Tel 0463-82-4751
Website https://www.fdsc.or.jp/

3 Recommended Contract Research Organizations
for Non-Clinical Studies
— by Target goal and Expertise

In non-clinical development, the choice of contract research organization shapes the quality of the data and the time it takes to reach the next decision. Below, three CROs are introduced by the type of study they support: pharmacology (efficacy) studies, safety studies, and pharmacokinetic (PK/PD) studies. Each summary describes the services the company offers so that you can match a provider to your target and development objective.

Pharmacology (Efficacy) StudiesDisease-Relevant Models for
Translational Drug Evaluation
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/)

SMC Laboratories, Inc.

SMC Laboratories is a specialized non-clinical CRO focused on in vivo pharmacology and efficacy studies using disease-relevant animal models, particularly in fibrosis, inflammation, metabolic diseases, and oncology.

Areas of Expertise
Disease-Relevant Model Portfolio

SMC Laboratories offers models covering the liver, lung, kidney, intestine, and oncology. Its portfolio includes the proprietary STAM™ model for MASH, fibrosis, and hepatocellular carcinoma.

Study Design Based on Target Biology

Study plans are developed around the target biology, mechanism of action, disease stage, and development objective. Pharmacological endpoints can be combined with histopathology, biomarkers, and disease-specific readouts.

Support from Target Validation to Proof of Concept

With experience from more than 1,000 studies for clients in 30 countries, SMC Laboratories supports programs from target validation and candidate selection through in vivo proof-of-concept studies.

Safety StudiesComprehensive Safety Assessment for
Preclinical Development
Charles River Laboratories
Reference: Charles River Laboratories official website (https://www.criver.com/)

Charles River Laboratories

Charles River provides non-clinical toxicology and safety assessment services for programs ranging from exploratory safety studies to IND-enabling development.

Areas of Expertise
General Toxicology Across Study Designs

Services include single- and repeat-dose toxicology, dose-range finding, and general toxicology studies across multiple species and administration routes.

Non-GLP and GLP Study Support

Charles River supports both non-GLP and GLP studies, allowing sponsors to progress from early safety characterization to studies intended for regulatory submissions.

Integrated IND-Enabling Safety Assessment

Toxicology studies can be integrated with toxicokinetics, clinical pathology, histopathology, and safety pharmacology to support interpretation and IND-enabling safety packages.

Pharmacokinetic (PK/PD) StudiesConnecting Drug Exposure with
Pharmacological Response
Inotiv
Reference: Inotiv official website (https://www.inotiv.com/)

Inotiv

Inotiv provides integrated PK/PD, DMPK, and bioanalytical services to characterize drug exposure and its relationship with pharmacological response.

Areas of Expertise
Pharmacokinetic Characterization

PK studies characterize exposure, half-life, clearance, and other pharmacokinetic parameters needed to understand how a candidate behaves in the selected model.

Exposure–Response Evaluation

Pharmacokinetic data can be combined with pharmacodynamic endpoints and bioanalysis to evaluate the relationship between drug exposure and pharmacological response.

Integrated DMPK and Development Support

Integrated DMPK, pharmacology, and safety information supports candidate comparison, dose selection, dosing-frequency optimization, and decisions about subsequent preclinical development.

By Therapeutic Area
Disease Animal Models
and Reviews
Proven Capability, Expertise and Track Record
Top 3 Non-Clinical CRO Services